Nos principales publications
- C.MJ. Lefeuvre, C.A. Payet, O-M. Fayet, S. Maillard, F. Truffault, V. Bondet, D. Duffy, V. de Monpreville, M-R. Ghigna, E. Fadel, A. Mansuet-Lupo, M. Alifano, P. Validire, D. Gossot, A. Behin, B. Eymard, S. Berrih-Aknin, R. Le Panse. Risk factors associated with myasthenia gravis in thymoma patients: the potential role of thymic germinal centers. Journal of Autoimmunity, 2020 Jan;106:102337.
- M.A. Cron, S. Maillard, F. Truffault, A.M. Gualeni, A. Gloghini, E. Fadel, J. Guihaire, A. Behin, S. Berrih-Aknin and R. Le Panse. Cause and consequences of miR-150-5p dysregulation in myasthenia gravis. Frontiers in Immunology 10; 539, 1-14, 2019.
- J.A. Villegas, A.C. Bayer, K. Ider, J. Bismuth, F. Truffault, R. Roussin, N. Santelmo, R. Le Panse, S. Berrih-Aknin and N Dragin. Role of IL-23/Th17 cell pathway: a promising target to alleviate thymic inflammation maintenance in myasthenia gravis. J. Autoimmunity (Epub ahead of print).
- Birnbaum S, Hogrel JY, Porcher R, Portero P, Clair B, Eymard B, Demeret S, Bassez G, Gargiulo M, Louët E, Berrih-Aknin S, Jobic A, Aegerter P, Thoumie P, Sharshar T; MGEX Study Group. The benefits and tolerance of exercise in myasthenia gravis (MGEX): study protocol for a randomised controlled trial. Trials. Jan 18;19(1):49, 2018.
- Crahès M, Bories MC, Vilquin JT, Marolleau JP, Desnos M, Larghero J, Soulat G, Bruneval P, Hagège AA, Menasché P. Long-Term Engraftment (16 Years) of Myoblasts in a Human Infarcted Heart. Stem Cells Transl Med. 7(10):705-708. 2018.
- V. Yilmaz, S. Maillard, F. Truffault, F. Bolgert, A. Behin, J.F. Reignard, S. Berrih-Aknin and R. Le Panse. Regulatory B cells in myasthenia gravis are differentially affected by therapies. Annals of Clinical Translational Neurology, 2018.
- J.A. Villegas, A. Gradolatto, F. Truffault, R. Roussin, S. Berrih-Aknin, R. Le Panse and N Dragin. Cultured Human Thymic-Derived Cells Display Medullary Thymic Epithelial Cell Phenotype and Functionality. Frontiers in Immunology 23; 9:1663, 2018.
- M.A. Cron, S. Maillard, F. Delisle, N. Samson, F. Truffault, M. Foti, E. Fadel, J. Guihaire, S. Berrih-Aknin and R. Le Panse. Analysis of microRNA expression in the thymus of Myasthenia Gravis patients opens new research avenues. Autoimmunity Review 17(6): 588-600, 2018.
- Praud C, Vauchez K, Zongo P, Vilquin JT. Modelling human myoblasts survival upon xenotransplantation into immunodeficient mouse muscle. Exp Cell Res.; 364(2):217-223, 2018.
- V. Mariot, R. Joubert, C. Hourdé, L. Féasson, M. Hanna, F. Muntoni, T. Maisonobe, L. Servais, R. Le Panse, O. Benvensite, T. Stojkovic, P.M. Machado, T. Voit, A. Buj-Bello, J. Dumonceaux. Reversible endogenous downregulation of myostatin pathway in muscle wasting neuromuscular diseases explains challenges of anti-myostatin therapeutic approaches. Nature communications 30; 8 (1): 1859, 2017.
- Mamrut S, Avidan N, Truffault F, Staun-Ram E, Sharshar T, Eymard B, Frenkian M, Pitha J, de Baets M, Servais L, Berrih-Aknin S, Miller A. Methylome and transcriptome profiling in Myasthenia Gravis monozygotic twins. J Autoimmun. Aug;82:62-73. doi: 10.1016/j.jaut.2017.05.005. Epub 2017 May 24, 2017.
- M. Robinet, S. Maillard, B. Villeret, M.A. Cron, S. Berrih-Aknin and R. Le Panse. Use of Toll-Like Receptor agonists to induce ectopic lymphoid structures in myasthenia gravis mouse models. Frontiers in Immunology, 25; 8: 1029 2017.
- M. Attia, M. Maurer, M. Robinet, F. Le Grand, E. Fadel, R. Le Panse, G. Buttler-Browne and S. Berrih-Aknin. Muscle satellite cells are functionally impaired in myasthenia gravis: consequences on muscle regeneration. Acta Neuropathologica – 134(6):869-888, 2017.
- N. Dragin, P. Nancy, J. Villegas, R. Roussin and R. Le Panse, and S. Berrih-Aknin. Balance between estrogens and proinflammatory cytokines regulates chemokine production involved in thymic germinal center formation. Scientific reports – 7 (1), 7970, 1-13, 2017.
- M. Sudres, M. Maurer, M. Robinet, J. Bismuth, F. Truffault, D. Girard, N. Dragin, M. Attia, E. Fadel, N. Santelmo, C. Sicsic, T. Brenner, S. Berrih-Aknin. Preconditioned mesenchymal stem cells treat myasthenia gravis in a humanized preclinical model. JCI Insight. Apr 6;2(7):e89665, 2017.
- N. Dragin, J. Bismuth, G. Cizeron-Clairac, M.G. Biferi, C. Berthault, A. Serraf, R. Nottin, D. Klatzmann, A. Cumano, M. Barkats, R. Le Panse, S. Berrih-Aknin. Estrogen-mediated downregulation of AIRE influences sexual dimorphism in autoimmune diseases. J. Clin. Invest. 126(4):1525-37, 2016.
- J. M. Weiss, M. Robinet, R. Aricha, P. Cufi, B. Villeret, F. Lantner, I. Shachar, M.C. Souroujon, S. Fuchs, S. Berrih-Aknin, R. Le Panse. Novel CXCL13 transgenic mouse: inflammation drives pathogenic effect of CXCL13 in experimental myasthenia gravis. Oncotarget 16-7(7):7550-62, 2016.
- S. Mamrut, N. Avidan, E. Staun-Ram, E. Ginzburg, F. Truffault, S. Berrih-Aknin and A. Miller. Integrative Analysis of Methylome and Transcriptome in Human Blood Identifies Extensive Sex- and Immune Cell-Specific Differentially Methylated Regions. Epigenetics 10 (10), 943-57, 2015.
